Case Study

Evaluation of Development Strategic Investment Options

Evaluation of Development Strategic Investment Options

Project Review: Case Study White Paper Technology Overview Healthcare Manufacturing Pharmaceutical Portfolio Government Logistics Financial Business Client Genre Vertical Evaluation of Development Strategic Investment Options ProModel Pharmaceutical Solutions pharmaVAO@promodel.com 888.437.0925 www.promodel.com Objectives Solution Situation A leading global pharmaceutical firm The firm invests close to $1 billion per year in Development Research to fuel the development pipeline with valuable drug opportunities. Appropriate allocation of these funds is critical to sustaining profitability. Because the business is so highly variable and unpredictable, management is always looking for more accurate ways to evaluate how various investment options affect the ability of Development to

Join for free to read